August 2021 Publications
- Engineering a new vaccine platform for heterologous antigen delivery in live-attenuated Mycobacterium tuberculosis. Broset E, Seral JC, Arnal C, Uranga S, Kanno AI, Leite LC, Martín, C, Gonzalo-Asensio J. Comput Struct Biotechnol J. 2021 Jul 30. doi: 10.1016/j.csbj.2021.07.035.
- Effect of BCG vaccination on proinflammatory responses in elderly individuals. Kumar, NP, Padmapriyadarsini C, Rajamanickam A, Marinaik SB, Nancy A, Padmanaban S, Akbar N, Murhekar M, Babu S. Science Advances. 2021 Aug 4. doi: 10.1126/sciadv.abg7181.
- Controlling inflammation in the elderly with BCG vaccination. Koeken VA. Science Advances. 2021 Aug 4. doi: 10.1126/sciadv.abk1668.
- Epidemiology of childhood tuberculosis after ceasing universal Bacillus Calmette-Guérin vaccination. Kobayashi S, Yoshiyama T, Uchimura K, Hamaguchi Y, Kato S. Sci Rep. 2021 Aug 5. doi:10.1038/s41598-021-95294-y.
- Interleukin-23 instructs protective multifunctional CD4 T cell responses after immunization with the Mycobacterium tuberculosis subunit vaccine H1 DDA/TDB independently of interleukin-17A. Ritter K, Behrends J, Erdmann H, Rousseau J, Hölscher A, Volz J, Prinz I, Lindenstrøm, T, Hölscher C. J Mol Med (Berl). 2021 Aug 5. doi: 10.1007/s00109-021-02100-3.
- Parental Bacillus Calmette-Guérin vaccine scars decrease infant mortality in the first six weeks of life: A retrospective cohort study. Berendsen MLT, Schaltz-Buchholzer F, Bles P, Biering-Sørensen S, Jensen KJ, Monteiro I, Silva I, Aaby P, Benn CS. EClinicalMedicine. 2021 Aug 12. doi: 10.1016/j.eclinm.2021.101049.
- Particulate Mycobacterial Vaccines Induce Protective Immunity against Tuberculosis in Mice. Chen S, Quan DH, Wang XT, Sandford S, Kirman JR, Britton WJ, Rehm BHA. Nanomaterials (Basel). 2021 Aug 13. doi: 10.3390/nano11082060.
- A recombinant bovine adenoviral mucosal vaccine expressing mycobacterial antigen-85B generates robust protection against tuberculosis in mice. Khan A, Sayedahmed EE, Singh VK, Mishra A, Dorta-Estremera S, Nookala S, Canaday DH, Chen M, Wang J, Sastry KJ, Mittal SK, Jagannath C. Cell Reports Medicine. 2021 Aug 17. doi: 10.1016/j.xcrm.2021.100372.
- Characterizing Early T Cell Responses in Nonhuman Primate Model of Tuberculosis. Sharan R, Singh DK, Rengarajan J, Kaushal, D. Front Immunol. 2021 Aug 17. doi: 10.3389/fimmu.2021.706723.
- CD4+CCR6+ T cells dominate the BCG-induced transcriptional signature. Singhania A, Dubelko P, Kuan R, Chronister WD, Muskat K, Das J, Phillips EJ, Mallal SA, Seumois G, Vijayanand P, Sette A, Lerm M, Peters B, Lindestam Arlehamn CS. Biorxiv. 20 Aug 2021. doi: 10.1101/2021.08.20.457054.
- ESX-5-targeted export of ESAT-6 in BCG combines enhanced immunogenicity & efficacy against murine tuberculosis with low virulence and reduced persistence. Heijmenberg I, Husain A, Sathkumara HD, Muruganandah V, Seifert J, Miranda-Hernandez S, Kashyap RS, Field, MA, Krishnamoorthy G, Kupz A. Vaccine. 2021 Aug 19. doi: 10.1016/j.vaccine.2021.08.030.
- A recombinant selective drug-resistant M. bovis BCG enhances the bactericidal activity of a second-line anti-tuberculosis regimen. Chiwala G, Liu Z, Mugweru JN, Wang B, Khan SA, Bate PNN, Yusuf B, Hameed HMA, Fang C, Tan Y, Guan P, Hu J, Tan S, Liu J, Zhong N, Zhang T. Biomed Pharmacother. 2021 Aug 21. doi: 10.1016/j.biopha.2021.112047.
- Immunogenicity of HspX/EsxS fusion protein of Mycobacterium tuberculosis along with ISCOMATRIX and PLUSCOM nano-adjuvants after subcutaneous administration in animal model. Avarvand AY, Meshkat Z, Khademi F, Tafaghodi M. Microbial Pathogenesis. 2021 Aug 27. doi.org/10.1101/2021.08.27.458002.
- Comparison TLR2 and TLR4 serum levels in children with pulmonary and extrapulmonary tuberculosis with and without a Bacillus Calmette-Guerin (BCG) scar. Shabariah R, Hatta M, Idris I, Santoso A, Patellongi I, Permatasari TAE, Farsida, Islam AA, Natzir R, Wahyudin B, Warsinggih, Emilda.J Clin Tuberc Other Mycobact Dis. 2021 Aug 31. doi: 10.1016/j.jctube.2021.100272. eCollection 2021 Dec.